EUDA Health Holdings Ltd Research and Development Expense
EUDA Health Holdings Ltd (EUDA) reported Research and Development Expense of $249 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-04-28
- EUDA Health Holdings Ltd research and development expense for the quarter ending 2022-03-31 was $2.95K.
- EUDA Health Holdings Ltd research and development expense for fiscal 2022 was $17.21K, a 86.69% decline from fiscal 2021.
- EUDA Health Holdings Ltd research and development expense for fiscal 2021 was $129.26K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 12 month |
|---|---|---|---|
| 2025-12-31 | $249.00 20-F · filed 2026-04-28 | ||
| 2025-06-30 | $244.00 6-K · filed 2025-10-01 | ||
| 2022-12-31 | $17.21K 10-K · filed 2023-06-28 | ||
| 2022-03-31 | $2.95K 10-Q · filed 2023-07-31 | ||
| 2021-12-31 | $129.26K 10-K · filed 2023-06-28 |